Literature DB >> 26668084

Clinical Impact of Abdominal Fat Distribution on Prognosis After Esophagectomy for Esophageal Squamous Cell Carcinoma.

Akihiko Okamura1, Masayuki Watanabe2, Shinji Mine1, Koujiro Nishida1, Yu Imamura1, Takanori Kurogochi1, Yuko Kitagawa3, Takeshi Sano1.   

Abstract

BACKGROUND: Excessive visceral fat may promote cancer development and progression because of metabolic derangements. The purpose of this study was to clarify the impact of abdominal fat distribution on patient prognosis after esophagectomy for esophageal squamous cell carcinoma (ESCC).
METHODS: Computed tomography volumetry was performed in 150 patients who underwent curative esophagectomy for ESCC between 2012 and 2013. Visceral fat area (VFA) and subcutaneous fat area (SFA) at umbilicus level were measured, and the VFA/SFA ratio was calculated in each patient. Prognoses of the patients were compared between groups classified according to VFA/SFA ratio.
RESULTS: Both relapse-free survival and overall survival of the low VFA/SFA group were significantly better than those of the high VFA/SFA group (log-rank test p = 0.005, p = 0.01). Univariate analysis also found that low VFA/SFA ratio significantly predicted an increase in relapse-free and overall survival. In multivariate analysis, low VFA/SFA ratio was an independent factor for relapse-free survival [p = 0.042, hazard ratio (HR) 0.12, 95 % confidence interval (CI) 0.01-0.93]. In addition, low VFA/SFA ratio tended to be a significant variable that predicted better overall survival (p = 0.057, HR 0.14, 95 % CI 0.01-1.05).
CONCLUSIONS: Low VFA/SFA ratio was significantly associated with better prognosis in patients who undergo curative esophagectomy for ESCC. Abdominal fat distribution may influence the biological features of ESCC.

Entities:  

Mesh:

Year:  2015        PMID: 26668084     DOI: 10.1245/s10434-015-5018-x

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  14 in total

1.  Lipid metabolism-related lncRNA SLC25A21-AS1 promotes the progression of oesophageal squamous cell carcinoma by regulating the NPM1/c-Myc axis and SLC25A21 expression.

Authors:  Yu Liu; Chunxiang Li; Lingling Fang; Liyu Wang; Hengchang Liu; He Tian; Yujia Zheng; Tao Fan; Jie He
Journal:  Clin Transl Med       Date:  2022-06

2.  Relationship Between Visceral Obesity and Postoperative Inflammatory Response Following Minimally Invasive Esophagectomy.

Authors:  Akihiko Okamura; Masayuki Watanabe; Ian Fukudome; Kotaro Yamashita; Masami Yuda; Masaru Hayami; Yu Imamura; Shinji Mine
Journal:  World J Surg       Date:  2018-11       Impact factor: 3.352

3.  Spirometric Lung Age Predicts Postoperative Pneumonia After Esophagectomy.

Authors:  Akihiko Okamura; Masayuki Watanabe; Shinji Mine; Koujiro Nishida; Takanori Kurogochi; Yu Imamura
Journal:  World J Surg       Date:  2016-10       Impact factor: 3.352

4.  Implication of visceral obesity in patients with esophageal squamous cell carcinoma.

Authors:  Akihiko Okamura; Masayuki Watanabe; Kotaro Yamashita; Masami Yuda; Masaru Hayami; Yu Imamura; Shinji Mine
Journal:  Langenbecks Arch Surg       Date:  2017-12-02       Impact factor: 3.445

5.  Preoperative Visceral Adiposity and Muscularity Predict Poor Outcomes after Hepatectomy for Hepatocellular Carcinoma.

Authors:  Yuhei Hamaguchi; Toshimi Kaido; Shinya Okumura; Atsushi Kobayashi; Hisaya Shirai; Siyuan Yao; Shintaro Yagi; Naoko Kamo; Satoru Seo; Kojiro Taura; Hideaki Okajima; Shinji Uemoto
Journal:  Liver Cancer       Date:  2018-06-05       Impact factor: 11.740

6.  High visceral fat percentage is associated with poor outcome in endometrial cancer.

Authors:  Karen Klepsland Mauland; Øyvin Eng; Sigmund Ytre-Hauge; Ingvild L Tangen; Anna Berg; Helga B Salvesen; Øyvind O Salvesen; Camilla Krakstad; Jone Trovik; Erling A Hoivik; Henrica Maria Johanna Werner; Gunnar Mellgren; Ingfrid S Haldorsen
Journal:  Oncotarget       Date:  2017-10-19

Review 7.  Dietary Fat and Cancer-Which Is Good, Which Is Bad, and the Body of Evidence.

Authors:  Bianka Bojková; Pawel J Winklewski; Magdalena Wszedybyl-Winklewska
Journal:  Int J Mol Sci       Date:  2020-06-09       Impact factor: 5.923

8.  Proposal for new selection criteria considering pre-transplant muscularity and visceral adiposity in living donor liver transplantation.

Authors:  Yuhei Hamaguchi; Toshimi Kaido; Shinya Okumura; Atsushi Kobayashi; Hisaya Shirai; Siyuan Yao; Shintaro Yagi; Naoko Kamo; Hideaki Okajima; Shinji Uemoto
Journal:  J Cachexia Sarcopenia Muscle       Date:  2018-02-17       Impact factor: 12.910

9.  Sarcopenia Predicts Prognosis in Patients with Newly Diagnosed Hepatocellular Carcinoma, Independent of Tumor Stage and Liver Function.

Authors:  Yeonjung Ha; Daejung Kim; Seungbong Han; Young Eun Chon; Yun Bin Lee; Mi Na Kim; Joo Ho Lee; Hana Park; Kyu Sung Rim; Seong Gyu Hwang
Journal:  Cancer Res Treat       Date:  2017-09-04       Impact factor: 4.679

10.  Prognostic value of subcutaneous adipose tissue volume in hepatocellular carcinoma treated with transcatheter intra-arterial therapy.

Authors:  Satoshi Yamagiwa; Takamasa Kobayashi; Hirokazu Kawai; Oki Nakano; Satoshi Abe; Hiroteru Kamimura; Akira Sakamaki; Kenya Kamimura; Atsunori Tsuchiya; Masaaki Takamura; Shuji Terai
Journal:  Cancer Manag Res       Date:  2018-07-25       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.